Elia Stupka serves as the Managing Director at Angelini Ventures, a global healthcare venture fund aimed at investing in and shaping future healthcare companies, since March 2021. Stupka is also a Strategic Advisor and General Manager for the Life Sciences Business at Health Catalyst, where responsibilities include enhancing clinical development and outcomes through extensive data from a vast provider network. Additional roles include Innovation Councilor at Cardea Bio Inc., Strategic Advisor positions at multiple organizations including leapcure, Duality Technologies, Entropica Labs, Pulse Infoframe Inc., and Reboot Rx, as well as Venture Partner at First Star Ventures. Stupka's academic credentials include a PhD in Computer Science from Leiden University, a Master's in Biomolecular Science from the University of York, and a Bachelor's in Biology from the same institution, complemented by programs at the MIT Sloan School of Management and United World College.